Investing.com - Nicox reported on Friday second quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Nicox announced earnings per share of €-0.16 on revenue of €700K. Analysts polled by Investing.com anticipated EPS of €-0.16 on revenue of €750K.
Nicox shares are down 26.42% from the beginning of the year, still down 47.99% from its 52 week high of €3.62 set on September 17, 2021.
Nicox follows other major Healthcare sector earnings this month
Nicox's report follows an earnings missed by Biomerieux on August 31, who reported EPS of €1.93 on revenue of €820.9M, compared to forecasts EPS of €2.22 on revenue of €719.4M.
Erytech Pharma had beat expectations on Monday with second quarter EPS of €-0.03 on revenue of €25.30M, compared to forecast for EPS of €-0.33 on revenue of €2.5M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar